{
    "links": "https://www.ycombinator.com/companies/kiwi-biosciences",
    "name": "Kiwi Biosciences",
    "headline": "Patent-pending enzymes to break down common dietary triggers",
    "batch": "S21",
    "description": "Kiwi Biosciences can help 18M Americans suffering from Irritable Bowel Syndrome (IBS) enjoy a normal meal without running to the bathroom two hours later. We develop novel, patent-pending enzymes that break down common digestive triggers in food.",
    "activity_status": "Active",
    "website": "https://www.fodzyme.com",
    "founded_date": 2020.0,
    "team_size": 10.0,
    "location": "Boston",
    "group_partner": "Diana Hu",
    "group_partner_yc": "https://www.ycombinator.com/people/diana-hu",
    "company_linkedin": null,
    "company_twitter": null,
    "tags": "industry:biotech; industry:food-tech; location:boston",
    "founders": [
        {
            "name": "Anjie Liu, Founder",
            "description": "Interdisciplinary thinker: scientifically-minded; humanist at heart \nJoint concentration in physics and comparative literature (Harvard 2017), now submerging myself into the intricate world of biology.\nI've struggled with chronic gut issues for most of my adult life, which led me to developing the current formulation of FODZYME and launching Kiwi Biosciences.",
            "linkedin": "https://www.linkedin.com/in/anjie-l-b2715810b/"
        },
        {
            "name": "David Hachuel Gurska, Founder",
            "description": "Formerly co-founder and CEO at auggi.ai, a digital gut health coach for patients with Irritable Bowel Syndrome (IBS). auggi was recently acquired by Seed Health. \nCompleted my MPH in Epidemiology at the Harvard School of Public Health and a Master's in Computer and Information Science at Cornell University.",
            "linkedin": "https://www.linkedin.com/in/david-hachuel/"
        }
    ],
    "status": true,
    "generated_description": "**Kiwi Biosciences: Revolutionizing Digestive Health**\n\nFounded in 2020 and hailing from Boston, Kiwi Biosciences is on a mission to provide relief to the 18 million Americans living with Irritable Bowel Syndrome (IBS). Their innovative and patent-pending enzymes target the common dietary triggers known as FODMAPs, allowing those affected to enjoy meals without the distress of digestive discomfort.\n\nYou might wonder: how does it work? Essentially, FODZYME\u00ae, Kiwi Biosciences' flagship product, is designed to break down these problematic substances in food, turning meals into a pleasurable experience rather than a potential trip to the bathroom. This unique approach aims to alleviate the restrictive diets that many IBS sufferers endure.\n\nThe company's journey began in Y Combinator's Batch S21, where it gained valuable exposure and support, setting the foundation for its growth. With a nimble team of ten, they are determined to tackle gut health problems head-on.\n\nKiwi Biosciences is not just another biotech startup; it's part of a growing movement that integrates food technology with health solutions. Alongside their advancements in enzyme treatments, they actively engage with their community through educational resources and subscription management systems, prioritizing user experience.\n\nKey Highlights:\n- **Founding Year**: 2020\n- **Location**: Boston, MA\n- **Team Size**: 10 employees\n- **Mission**: To develop enzymes that aid in digesting FODMAPs, easing the life of IBS sufferers.\n- **Website**: [FODZYME](https://www.fodzyme.com)\n\nIf you're among those struggling with gut health, Kiwi Biosciences could be the key to unlocking a wider range of foods. It's about time we made mealtime enjoyable again, right?",
    "logo": "https://bookface-images.s3.us-west-2.amazonaws.com/logos/21f60cca8abe1b2c5f1966704e77c9da8fe3b8b2.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAEHIR6H6F%2F20250221%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20250221T191452Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDt736ZW5EfzagAz1eKRSs%2FW4TfHu28RBSFaRNkZ9h47gIhANt6WXtwkgL07bQKDKYDGFxYKx7WOO9JX0BqaYrXnKNbKu4DCNz%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMMDA2MjAxODExMDcyIgx8TqkMwTM2PLcRmr4qwgPGGtQBXv7gs7%2BXGteI1gQk%2FjkbIHwQ5hCKXJKVmVAPw3MeVLhZyp8Nf5%2FYigbwE%2BrFR7aZWKjrs7HxAE0JWit5dlINZLjZK%2BS%2FwMaCqoj%2BFDN0gw9iiAPu4Xn5c3b%2BuZe%2F5%2Flfk0EuxZAXVsZtShxXZy%2FERPQ0v%2FRZxSz5qUoaXpL1zj6VWdWVzoI7%2FPlB3bgJ2PpiF7DN%2BJeDsJPx%2FoKTo5ehP9pOeGbMNxoeegVJsCJ3zvzO3o4fcZYIf6c5iIJwM1Ot3Gg7Z3v9oLZjSRU%2FaRLL5j4n3II7DaroOCEVfPlWzTyZM7SNFZZAFSKM8vLKj1VdTr9s3How41zluf%2FOIp7sGNhG%2FjuYJoG%2FmkLFIlYP4wbGrLO69AWnenZyfi1UhAiV6N%2BlAqGnqvpOJh4vq8uNh2eRnXR%2BMVXdq9oVYkm7XFgprL5PDC4ULLyBWqA6kca4z7F4H56nkT%2FsDtT8ek2VOIRIv1Zgcz%2BeeVG7F7AHS4bdbR6eZ3ChY1iQhfPBErh4OiFQM7IqiUKw%2B1CTpvL68xcVN5gjiaDH0Jotw%2BUcW9dMSg9py8xH8qgyiWG5w3dDj9xaoA2G3NMYq6JOGKMwwIrjvQY6pAHDH54nhADhmb7YSEGxHkL3pqs%2B6aYOExStWbzLKzRb3lb2DAgGG8uU9COt8%2FqUEOtOcszTKp7yuCJwMVkfI7PDZ74h9uiRkRxjtH7%2BLlE1xrfd%2FrIq%2B%2BZr9hSFqZ9MUQ4yNHesyx2FYDbsIfCW9ntlrpmZUHCcrzpQDfufsAFcpe%2FudVT3tUqiF8WCN1Vd%2Bx%2FQ9d3i1HvBcJWV9AYAwM0W22VM%2BA%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=8c614f60c44a459866652c00d4e18ba94902e24efb9070bb5464e90118ec7f09",
    "social_links": [
        "https://www.linkedin.com/company/kiwi-biosciences",
        "https://twitter.com/fodzyme"
    ],
    "logo_path": "data/logos\\Kiwi_Biosciences_logo.png"
}